Company / Current Assets per Share
AVADEL PHARMACEUTICALS PLC Current Assets per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$1.41
FY2024
5-year range
$1.41 / $4.80
FY2020-FY2024
Trend
-15.7%
vs FY2023
Sector context
#186 of 210
Health Care
What the data says
AVADEL PHARMACEUTICALS PLC's current assets per share of $1.41 is lower than 89% of companies in the Health Care sector (FY2024). Current Assets per Share has declined for 4 consecutive years, from $4.80 in FY2020 to $1.41 in FY2024.
Based on SEC 10-K filings.
1.41 in FY2024 with a 5-year CAGR of -8.5%.
Declined from $1.68 to $1.41 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -24.6%
- 5-Year CAGR
- -8.5%
- 10-Year CAGR
- -
Sector benchmark
Bottom 11% in Health CareTop 89% of 210This company $1.41 Sector average $170.65
▼
-99.2% below sector average
Key checks
Key Insights
- AVADEL PHARMACEUTICALS PLC's current assets per share has declined for 4 consecutive years.
- In FY2024, current assets per share decreased 15.7% year-over-year.
- Ranks #186 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -28.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $1.41 | -15.7% |
| FY2023 | $1.67 | -0.3% |
| FY2022 | $1.68 | -49.0% |
| FY2021 | $3.29 | -31.4% |
| FY2020 | $4.80 | +117.7% |
| FY2019 | $2.20 | -34.2% |
| FY2018 | $3.34 | +12.7% |
| FY2017 | $2.97 | -32.4% |
| FY2016 | $4.39 | +15.1% |
| FY2015 | $3.81 | +23.0% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026